| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.089 | 0.04 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |